3-Bromo-5-nitro-1H-indazole - CAS 67400-25-3
Catalog: |
BB033270 |
Product Name: |
3-Bromo-5-nitro-1H-indazole |
CAS: |
67400-25-3 |
Synonyms: |
3-bromo-5-nitro-2H-indazole; 3-bromo-5-nitro-2H-indazole |
IUPAC Name: | 3-bromo-5-nitro-2H-indazole |
Description: | 3-Bromo-5-nitro-1H-indazole (CAS# 67400-25-3) is a useful research chemical. |
Molecular Weight: | 242.03 |
Molecular Formula: | C7H4BrN3O2 |
Canonical SMILES: | C1=CC2=NNC(=C2C=C1[N+](=O)[O-])Br |
InChI: | InChI=1S/C7H4BrN3O2/c8-7-5-3-4(11(12)13)1-2-6(5)9-10-7/h1-3H,(H,9,10) |
InChI Key: | SYTGRKBQTUKOAI-UHFFFAOYSA-N |
Boiling Point: | 257 °C at 760 mmHg |
Density: | 1.965 g/cm3 |
MDL: | MFCD07367964 |
LogP: | 2.75680 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P310, P321, P330, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111875594-A | Indazole heterocycles having phosphodiesterase 4B inhibitory activity | 20200721 |
WO-2021194878-A1 | Selective modulators of mutant lrrk2 proteolysis and associated methods of use | 20200321 |
WO-2021178780-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 20200306 |
KR-20210076879-A | Novel pyrimidine derivatives and use thereof | 20191216 |
WO-2021125803-A1 | Novel pyrimidin derivative and use thereof | 20191216 |
Complexity: | 220 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 240.94869 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 240.94869 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 74.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Indazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS